Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Processa Pharmaceuticals Inc (NQ: PCSA )

2.230 +0.610 (+37.65%)
Streaming Delayed Price Updated: 11:08 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 56,994,200
Open 2.460
Bid (Size) 2.220 (8)
Ask (Size) 2.230 (4)
Prev. Close 1.620
Today's Range 2.160 - 2.680
52wk Range 0.1801 - 5.910
Shares Outstanding 2,855,981
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Dow Dips Over 500 Points; US GDP Growth Misses Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
+530.48%
+530.48%
1 Month
-0.89%
-0.89%
3 Month
+8.78%
+8.78%
6 Month
+575.76%
+575.76%
1 Year
+316.82%
+316.82%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Presents New Data from NGC-Cap Phase 1b Trial at AACR Annual Meeting
Via Investor Brand Network
Exposures Product Safety
How Is The Market Feeling About Processa Pharma?
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
Via Investor Brand Network
Exposures Product Safety
TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at American Association for Cancer Research Annual Meeting
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference
Via Investor Brand Network
Exposures Product Safety
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public Offering
Via Investor Brand Network
Exposures Product Safety
Expensify And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
Via AB Newswire
Topics Retirement
Exposures Pension
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results
Via Benzinga
Topics Stocks
Exposures US Equities
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Pricing Information for $7M Public Offering
Via Investor Brand Network
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 1%; American Express Shares Rise After Q4 Results
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
What's Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?
Via Benzinga
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
From Processa Pharmaceuticals, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.